Under the Omnibus Rule, which of the following is a permissible use of PHI for health care operations WITHOUT individual authorization?
-
A
Selling PHI to a pharmaceutical company for drug marketing
-
B
Sharing PHI with a sister covered entity for joint quality improvement activities
-
C
Disclosing PHI to an employer for workplace wellness incentive tracking
-
D
Providing PHI to a data broker for analytics resale